ArticleRSC advances2025
Kinetic study on the hydrogenation of dimethyl succinate to γ-butyrolactone.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The hydrogenation of dimethyl succinate (DMS) to γ-butyrolactone (GBL) is crucial in producing high-value chemicals for pharmaceuticals, agrochemicals, and battery electrolytes. This study utilized a self-developed copper-based catalyst and a micro-fixed bed reactor to systematically investigate the effects of temperature, pressure, and the hydrogen-to-ester ratio on reaction performance. An intrinsic kinetic model was developed based on experimental data, with reaction rate constants and activation energies determined through standard regression techniques. The model correlated well with observed data, providing insights into reaction kinetics. Validation against experimental data indicated fair agreement across various conditions. Sensitivity analysis confirmed the model's robustness, making it useful for process optimization. This kinetic analysis offers insights to enhance the efficiency and cost-effectiveness of industrial GBL production, aiming to improve overall process yield and efficiency.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.